Nucleotide substitution: C?T.
Amino acid replacement: S17F.
C19870455T
C?T
S17F | Rab8-PA; S17F | Rab8-PC
S17F
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
abnormal neuroanatomy | third instar larval stage (with Rab8B229), with Rab8UAS.cWa, Scer\GAL4Mhc.PW
axoneme | spermatogenesis (with Df(3L)ED228)
Rab81/Df(3L)ED228 spermatocytes show elongated primary axonemes (labelled by CG6652).
Rab81 homozygous clone cells within a mosaic follicular epithelium deposit basement membrane components on both basal and apical extracellular sides, as compared to only on the basal side in controls.
Rab81/Rab82 mutants show pharate lethality.
Rab81/Rab8B229 mutants show pharate lethality.
All the tested trans-heterozygous allelic combinations of Rab81 mutants display synaptic overgrowth, characterized by significant increase in synaptic bouton number of up to 100% relative to wild-type. The synaptic overgrowth is highly penetrant affecting every neuromuscular junction (NMJ) observed including both muscles 6/7 and 4.
In addition to elevated bouton number, Rab81/Rab8B229 mutants also have a significant increase in neuromuscular junction length, branching, and satellite bouton number, with reduction in synaptic bouton size.
Postsynaptic expression of Rab8Scer\UAS.cWa under the control of Scer\GAL4Mhc.PW rescues the increased synaptic bouton number phenotype at muscle 6/7, but not synapse length at neuromuscular junctions in Rab81/Rab8B229 mutants.
Synaptic bouton number or length in muscle 4 is not rescued by muscle expression of Rab8Scer\UAS.cWa.
Rab81/Rab8B229 mutants display a clear reduction in both fast and slow recycling endosomes at both the NMJ and in motor neuron cell bodies in the larval ventral nerve cord. Upon ultrastructural analysis of mutant synapses, accumulation of large endosome-like, intermediary structures within synaptic boutons are observed. The observed structures, however, are dissimilar and unlikely synaptic vesicles as they are not released, because there is no increase in quantal size during electrophysiological analysis. On the contrary, Rab81/Rab8B229 mutants show decreased quantal size compared with wild-type. These structures are similar to autophagosomal intermediates and they are never observed in wild-type animals.
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by tkv7/tkv[+]
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by tkvk16713/tkv[+]
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by tkvk16713/tkv7
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by Scer\GAL4RapGAP1-OK6/kayFbz.UAS
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by Scer\GAL4nSyb.PS/kayFbz.UAS
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by POSHEP1206
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by POSHEP2248
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by Tak1[+]/Tak1179
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by Tak1RNAi.UAS.cUa/Scer\GAL4nSyb.PS
Rab81/Rab8B229 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by Tak1K46R.M.UAS/Scer\GAL4nSyb.PS
Rab81 is an enhancer of visible phenotype of Hsap\CHMP2BIntron5.UAS, Scer\GAL4GMR.PF
HrsD28, Rab81/Rab8[+] has abnormal neuroanatomy phenotype
Rab81/Rab8[+], pucE69 has abnormal neuroanatomy phenotype
DadΔIEL, Rab81/Rab8[+] has abnormal neuroanatomy phenotype
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by HrsUAS.cUa/Scer\GAL4nSyb.PS
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by tkv7/tkv[+]
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by POSHEP1206
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by POSHEP1206
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by POSHEP2248
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by POSHEP2248
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Tak1[+]/Tak1179
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by Tak1[+]/Tak1179
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Tak1RNAi.UAS.cUa/Scer\GAL4nSyb.PS
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by Tak1RNAi.UAS.cUa/Scer\GAL4nSyb.PS
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Tak1K46R.M.UAS/Scer\GAL4nSyb.PS
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by Tak1K46R.M.UAS/Scer\GAL4nSyb.PS
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by tkvk16713/tkv[+]
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by HrsUAS.cUa/Scer\GAL4nSyb.PS
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by tkvk16713/tkv[+]
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by tkvk16713/tkv7
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by tkvk16713/tkv7
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Scer\GAL4RapGAP1-OK6/kayFbz.UAS
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by Scer\GAL4RapGAP1-OK6/kayFbz.UAS
Rab81/Rab8B229 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Scer\GAL4nSyb.PS/kayFbz.UAS
Rab81/Rab8B229 has NMJ bouton | third instar larval stage phenotype, suppressible by Scer\GAL4nSyb.PS/kayFbz.UAS
Rab81 is an enhancer of axoneme | spermatogenesis phenotype of Fam92c.4-789Del
Rab81 is an enhancer of axoneme | spermatogenesis phenotype of Cbyc.121delC
Rab81 is an enhancer of eye phenotype of Hsap\CHMP2BIntron5.UAS, Scer\GAL4GMR.PF
HrsD28, Rab81/Rab8[+] has NMJ bouton | third instar larval stage phenotype
HrsD28, Rab81/Rab8[+] has embryonic/larval neuromuscular junction | third instar larval stage phenotype
Rab81/Rab8[+], pucE69 has NMJ bouton | third instar larval stage phenotype
Rab81/Rab8[+], pucE69 has embryonic/larval neuromuscular junction | third instar larval stage phenotype
DadΔIEL, Rab81/Rab8[+] has NMJ bouton | third instar larval stage phenotype
DadΔIEL, Rab81/Rab8[+] has embryonic/larval neuromuscular junction | third instar larval stage phenotype
When present in the genetic background, heterozygous tkv7 reduces the synaptic overgrowth in Rab81/Rab8B229 mutants.
When present in the genetic background, heterozygous tkvk16713 reduces the synaptic overgrowth in Rab81/Rab8B229 mutants.
When present in the genetic background, trans-heterozygous tkv7/tkvk16713 reduces the synaptic overgrowth in Rab81/Rab8B229 mutants.
Although heterozygous Rab81 or DadΔIEL mutants alone do not show any perturbation to synaptic bouton number, their heterozygous combination engenders an increased bouton number compared to wild-type.
Neuronal expression of kayFbz.Scer\UAS under the control of Scer\GAL4RapGAP1-OK6 is sufficient to completely alleviate the synaptic overgrowth in Rab81/Rab8B229 mutants.
Neuronal expression of kayFbz.Scer\UAS under the control of Scer\GAL4nSyb.PS is sufficient to completely alleviate the synaptic overgrowth in Rab81/Rab8B229 mutants.
Heterozygous combinations of pucE69 and Rab81 results in an increase in synaptic bouton number compared with wild-type.
Introducing POSHEP1206 into a Rab81/Rab8B229 mutant background alleviates the synaptic overgrowth phenotype.
Introducing POSHEP2248 into a Rab81/Rab8B229 mutant background alleviates the synaptic overgrowth phenotype.
Rab81/Rab8B229 is partially rescued by Scer\GAL4Act5C.PI/Rab8UAS.cWa
Rab81/Rab8B229 is partially rescued by Scer\GAL4nSyb.PS/Rab8UAS.cWa
Rab81/Rab8B229 is partially rescued by Scer\GAL4Mhc.PW/Rab8UAS.cWa
Expression of Rab8Scer\UAS.cWa under the control of Scer\GAL4Act5C.PI and the presynaptic driver Scer\GAL4nSyb.PS is sufficient to completely rescue the increased bouton number at muscles 6/7 Rab81/Rab81 mutants.
Postsynaptic expression of Rab8Scer\UAS.cWa under the control of Scer\GAL4Mhc.PW rescues the increased synaptic bouton number phenotype at muscle 6/7, but not synapse length at neuromuscular junctions in Rab81/Rab8B229 mutants.
Synaptic bouton number or length in muscle 4 is not rescued by muscle expression of Rab8Scer\UAS.cWa.
J. Kennison
Isolated in a screen for lethal mutations that fail to complement Df(3L)kto2.